Comparison
46 Xx True Hermaphroditism Sry Positive Cn322638 vs 3 Methylglutaric Aciduria C3151952
Clinical comparison between 46 XX True Hermaphroditism Sry Positive CN322638 and 3 Methylglutaric Aciduria for differential diagnosis and treatment planning.
46 Xx True Hermaphroditism Sry Positive Cn322638
A rare DSD where an individual has both ovarian and testicular tissue. Occurs in 46,XX persons, often with SRY gene present. Management includes hormone therapy and individualized surgical options.
3 Methylglutaric Aciduria C3151952
An organic acidemia affecting how the body processes certain amino acids. It can cause neurological problems and metabolic crises. Management involves dietary changes and supportive treatment.
6 comparison axes
Onset
46 Xx True Hermaphroditism Sry Positive Cn322638
0-0
3 Methylglutaric Aciduria C3151952
0-10
Onset patterns differ
Severity
46 Xx True Hermaphroditism Sry Positive Cn322638
severe
3 Methylglutaric Aciduria C3151952
moderate
Different severity levels
Chronic
46 Xx True Hermaphroditism Sry Positive Cn322638
Chronic
3 Methylglutaric Aciduria C3151952
Chronic
Differing course
Communicable
46 Xx True Hermaphroditism Sry Positive Cn322638
No
3 Methylglutaric Aciduria C3151952
No
Different transmission
Body System
46 Xx True Hermaphroditism Sry Positive Cn322638
reproductive
3 Methylglutaric Aciduria C3151952
metabolic
Same/different system
Category
46 Xx True Hermaphroditism Sry Positive Cn322638
genetic
3 Methylglutaric Aciduria C3151952
metabolic
Different category
Bottom line
46-xx-true-hermaphroditism-sry-positive-CN322638 and 3-methylglutaric-aciduria-C3151952 differ in severity, etiology
Key differentiating points
Findings that most reliably separate the two conditions at the bedside or in the workup.
| Feature | 46 Xx True Hermaphroditism Sry Positive Cn322638 | 3 Methylglutaric Aciduria C3151952 | Discriminating power |
|---|---|---|---|
| Genital or gonadal development | Atypical genitalia may occur, with both ovarian and testicular tissue. | Genital development is not the defining feature. | High |
| Metabolic crisis | Not described as causing metabolic decompensation. | May cause metabolic crises related to impaired amino-acid processing. | High |
| Onset pattern | Congenital, with supplied onset coded 0-0. | Supplied onset spans birth to about age 10. | Moderate |
When to favor each condition
Choose 46 Xx True Hermaphroditism Sry Positive Cn322638 when
Newborn with atypical genitalia and 46,XX karyotype
Source links this condition to mixed gonadal tissue and often SRY.
High
Evaluation of sex development
Karyotype, SRY status, and gonadal findings separate it from acidemia.
High
Planning endocrine or surgical care
Management may involve hormones and individualized surgery, not acidemia diet.
Moderate
Choose 3 Methylglutaric Aciduria C3151952 when
Child with neurologic problems and suspected organic acidemia
Source describes impaired amino-acid processing and neurologic effects.
High
Episodic metabolic decompensation
Metabolic crises are stated for aciduria but not for the DSD.
Moderate
Abnormal organic acids without a DSD
Supports considering aciduria, but clinician confirmation is required.
Moderate
How key tests differ
| Test | 46 Xx True Hermaphroditism Sry Positive Cn322638 | 3 Methylglutaric Aciduria C3151952 | Interpretation |
|---|---|---|---|
| Karyotype and SRY testing | 46,XX, often with SRY present. | Not defined by sex chromosomes or SRY. | Supports DSD classification; it does not diagnose aciduria. |
| Gonadal assessment | Ovarian and testicular tissue may be identified. | Not the primary diagnostic target. | Tissue findings support ovotesticular DSD; absence does not exclude aciduria. |
| Urine organic acids | No specific pattern is established in the source. | An organic-acid pattern may be sought; cutoffs are not supplied. | Abnormal metabolites suggest aciduria but are not a diagnosis alone. |
Prognosis comparison
46 Xx True Hermaphroditism Sry Positive Cn322638
- Outcome
- Chronic congenital condition; outcome depends on anatomy, hormones, and care. Mortality is not established.
- Factors
- Gonadal findings, endocrine function, treatment choices, and psychosocial support.
3 Methylglutaric Aciduria C3151952
- Outcome
- Chronic moderate-coded metabolic disorder; crises and neurologic effects may shape outcome. Mortality is not established.
- Factors
- Crisis prevention, neurologic status, dietary management, and supportive care.
Time frame: Lifelong; DSD is present from birth, while aciduria onset is described from 0 to 10 years.
Early specialist assessment and monitoring matter, but source data are sparse.
Complications comparison
| Complication | Presentation |
|---|---|
| Gonadal or fertility concerns | Possible because mixed gonadal tissue is defining. Not a stated complication. Malignancy risk is not quantified here; specialist follow-up is needed. |
| Metabolic crisis | Not established. May occur, with unspecified triggers and frequency. Suspected crisis needs urgent metabolic assessment. |
| Neurologic effects | Not a defining complication. Neurologic problems are described. Severity varies; no mortality estimate is established. |
Patient education highlights
- HighDistinct conditions
One is a congenital difference of sex development; the other is a metabolic acidemia. Neither is communicable.
- HighUrgent symptoms
For suspected aciduria, vomiting, lethargy, or neurologic change needs prompt clinical advice. Thresholds are not established here.
- MediumIndividualized care
DSD care may include hormones and surgery decisions; aciduria care may include diet and support. No doses are provided.